Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Safety and Efficacy of Intracanalicular Dexamethasone Inserts for the Control of Inflammation and Discomfort in Dry Eye disease (DECIDED) - A Randomized, Sham-Controlled Trial

William Binotti; Dilruba Koseoglu; Sandra Hunt; Cuneyt Ozmen; Leyla Yavuz-Saricay; Betul Nurefsan Bayraktutar; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):201.

ARVO Annual Meeting Abstract June 2025

Phenotypes of ocular surface disease patients treated at various practice modalities demonstrate significant differences in clinical paramters

Stephanie Cox; Milton M Hom; Loretta Szczotka-Flynn; Nancy Gee; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4490.

ARVO Annual Meeting Abstract June 2025

A Demonstration of the Necessity of Analyzing all Dendritiform Cells to Obtain Accurate Morphological Characteristics

Anjali Thaivalappil; Stephanie Cox; Armita Hamrah; Neslihan Dilruba Koseoglu; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4464.

ARVO Annual Meeting Abstract June 2025

The Utility of Assessing Corneal Nerve Function through In-Office Drop Responses to Distinguish Patients with Neuropathic Corneal Pain from Dry Eye Disease

Sandra Hunt; Stephanie Cox; Neslihan Dilruba Koseoglu; Gabriela Dieckmann; Mehmet Cuneyt Ozmen; William Binotti; Anam Akhlaq; Betul Nurefsan Bayraktutar; Ana Balbuena-Pareja; Chloe Bogen; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3756.

ARVO Annual Meeting Abstract June 2025

Presenting Symptoms in Patients with Neuropathic Corneal Pain with Underlying Small Fiber Neuropathy

Neslihan Dilruba Koseoglu; Chloe Bogen; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3751.

ARVO Annual Meeting Abstract June 2025

Efficacy of self–retained cryopreserved amniotic membrane transplantation in neurotrophic keratopathy patients

Isabela Yang; Neslihan Dilruba Koseoglu; Ana Balbuena-Pareja; Benjamin Byung-Joon Lee; Chloe Bogen; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3745.

ARVO Annual Meeting Abstract June 2024

An exploratory, prospective, interventional, open-label, clinical trial with intranasal neurostimulation for ameliorating symptoms of neuropathic corneal pain

Onur Olcucu; Gabriela Dieckmann; Mehmet Cuneyt Ozmen; Stephanie Cox; Ginny Liu; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2658.

ARVO Annual Meeting Abstract June 2024

Phenotypic Analysis of Neuropathic Corneal Pain Demonstrates Six Differential Clusters Using Clinical Variables

Chloe Bogen; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2656.

ARVO Annual Meeting Abstract June 2024

The Effect of an Anti-Inflammatory Diet on Patient Outcomes in Ocular Surface Disease Patients

Anupa Thirmiya; Sandra Hunt; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3699.

ARVO Annual Meeting Abstract June 2023

Decrease in total corneal nerve density and presence of activated dendritiform cells by in vivo confocal microscopy in patients with dry eye disease is correlated with increased levels of pain

Stephanie Cox; Julia Citron; Nishanth Ganeshbbu; Rebecca Graham; Gabriela Dieckmann; Anya de Leeuw; Betul Bayraktutar; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):OD31.

ARVO Annual Meeting Abstract June 2023

Association of Clinical Signs with the Ocular Surface Disease Index: Preliminary Results from the Multicenter Neurosensory Abnormalities in ocular SurfAce Disease (NASA) study

Milton M Hom; Stephanie Cox; Loretta Szczotka; Nancy S. Gee; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):203.

ARVO Annual Meeting Abstract June 2023

Role of Vitamin Abnormalities as Possible Underlying Etiology in Patients with Neuropathic Corneal Pain

Chloe S Bogen; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):721.

ARVO Annual Meeting Abstract June 2023

Dry eye patients with severely reduced nerve fiber density at the level of neurotrophic keratitis, present with signs and symptoms similar to conventional dry eye patients

Julia Citron; Stephanie Cox; Nishanth Ganeshbbu; Rebecca Graham; Anya de Leeuw; Betul Bayraktutar; Gabriela Dieckmann; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2878.

ARVO Annual Meeting Abstract June 2023

Patients with post-surgical dry eye disease demonstrate decreased corneal nerve density and increased density of dendritiform cells by in vivo confocal microscopy compared to non-surgical dry eye patients

Nishanth Ganeshbbu; Stephanie Cox; Julia Citron; Rebecca Graham; Betul Bayraktutar; Gabriela Dieckmann; Anya de Leeuw; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3989.

ARVO Annual Meeting Abstract June 2023

Anterior segment-optical coherence tomography (AS-OCT) epithelial thickness mapping may provide a novel tool to differentiate neurotrophic keratopathy from dry eye disease

Luiz Luciano Lamazales; William Binotti; Stephanie Cox; Ana Balbuena-Pareja; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3604.

ARVO Annual Meeting Abstract June 2023

Cenegermin 0.002% treatment results in improvement in corneal sensation and corneal nerve regeneration in patients with Neurotrophic Keratopathy

Ana Balbuena-Pareja; Chloe S Bogen; Stephanie Cox; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4030.

ARVO Annual Meeting Abstract June 2022

Ocular Surface Disease Patients with Microneuromas also have Reduced Nerves

Stephanie Cox; Betul Bayraktutar; Anya de Leeuw; Gabriela Dieckmann; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1222 – A0222.

ARVO Annual Meeting Abstract June 2022

Comparison of ocular surface disease in patients between two different clinical settings: Preliminary results from the Neurosensory Abnormalities in ocular SurfAce Disease (NASA) study

Milton M Hom; Stephanie Cox; Loretta Szczotka-Flynn; Nancy Gee; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1564 – A0289.

ARVO Annual Meeting Abstract June 2021

Comparison and Correlation of Schirmer’s Tests Results in Patients with Neuropathic Corneal Pain and Dry Eye Disease

Anya de Leeuw; Brendan Kenyon; Stephanie Cox; Leyla Yavuz-Saricay; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1279.

ARVO Annual Meeting Abstract June 2021

Corneal in vivo confocal microscopy demonstrates correlations between morphological changes in dendritiform cells and corneal nerve alterations in patients with dry eye disease

Stephanie Cox; Betul Bayraktutar; Gabriela Dieckmann; Pedram Hamrah

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1222.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Safety and Efficacy of Intracanalicular Dexamethasone Inserts for the Control of Inflammation and Discomfort in Dry Eye disease (DECIDED) - A Randomized, Sham-Controlled Trial

Phenotypes of ocular surface disease patients treated at various practice modalities demonstrate significant differences in clinical paramters

A Demonstration of the Necessity of Analyzing all Dendritiform Cells to Obtain Accurate Morphological Characteristics

The Utility of Assessing Corneal Nerve Function through In-Office Drop Responses to Distinguish Patients with Neuropathic Corneal Pain from Dry Eye Disease

Presenting Symptoms in Patients with Neuropathic Corneal Pain with Underlying Small Fiber Neuropathy

Efficacy of self–retained cryopreserved amniotic membrane transplantation in neurotrophic keratopathy patients

An exploratory, prospective, interventional, open-label, clinical trial with intranasal neurostimulation for ameliorating symptoms of neuropathic corneal pain

Phenotypic Analysis of Neuropathic Corneal Pain Demonstrates Six Differential Clusters Using Clinical Variables

The Effect of an Anti-Inflammatory Diet on Patient Outcomes in Ocular Surface Disease Patients

Decrease in total corneal nerve density and presence of activated dendritiform cells by in vivo confocal microscopy in patients with dry eye disease is correlated with increased levels of pain

Association of Clinical Signs with the Ocular Surface Disease Index: Preliminary Results from the Multicenter Neurosensory Abnormalities in ocular SurfAce Disease (NASA) study

Role of Vitamin Abnormalities as Possible Underlying Etiology in Patients with Neuropathic Corneal Pain

Dry eye patients with severely reduced nerve fiber density at the level of neurotrophic keratitis, present with signs and symptoms similar to conventional dry eye patients

Patients with post-surgical dry eye disease demonstrate decreased corneal nerve density and increased density of dendritiform cells by in vivo confocal microscopy compared to non-surgical dry eye patients

Anterior segment-optical coherence tomography (AS-OCT) epithelial thickness mapping may provide a novel tool to differentiate neurotrophic keratopathy from dry eye disease

Cenegermin 0.002% treatment results in improvement in corneal sensation and corneal nerve regeneration in patients with Neurotrophic Keratopathy

Ocular Surface Disease Patients with Microneuromas also have Reduced Nerves

Comparison of ocular surface disease in patients between two different clinical settings: Preliminary results from the Neurosensory Abnormalities in ocular SurfAce Disease (NASA) study

Comparison and Correlation of Schirmer’s Tests Results in Patients with Neuropathic Corneal Pain and Dry Eye Disease

Corneal in vivo confocal microscopy demonstrates correlations between morphological changes in dendritiform cells and corneal nerve alterations in patients with dry eye disease

To View More...

You must be signed into an individual account to use this feature.